NCT03437564View on ClinicalTrials.gov

A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

February 16, 2018

Primary Completion Date

April 13, 2018

Study Completion Date

April 13, 2018

Conditions

Healthy Adult Participants

Interventions

DRUG

Vortioxetine

Vortioxetine tablet

Trial Locations (1)

Unknown

Nishi Kumamoto Hospital, Kumamoto

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY